Search - tctmd.com

Presenter: Dimytri A. Siqueira, David LeBihan, Lucas Arraes, Alexandre A.C Abizaid, Rodrigo Barreto, Magali Arrais, Auristela Ramos, Manuel N. Cano, Antonio Kambara, Adriana C. Moreira, Jorge Assef, Fausto Feres, Eberhard Grube, Amanda GMR Sousa, J. Eduardo M.R. Sousa

January 03, 2012

Presentation TCT 2012

The Impact of Commissural Morphology on Clinical Outcome in Patients Undergoing Percutaneous Balloon Mitral Valvuloplasty

Presenter: Mohamed A. Sadaka, Eman Elsharkawy, Magdy Rashwan, Rasha Abdo

January 03, 2012

Presentation TCT 2012

Long-term Follow-up of Mitral Valvuloplasty with Single Balloon. Independent Predictors of Survival and Event Free Survival

Presenter: Edison S. Peixoto, Ricardo S. Peixoto, Rodrigo S. Peixoto, Ivana P. Borges, Paulo S. Oliveira, Aristarco G. Siqueira-Filho

January 03, 2012

Presentation TCT 2012

Balloon Aortic Valvuloplasty as a Bridging Thearpy to Aortic Valve Replacement or Transcatheter Aortic Valve Implantation

Presenter: Michael Tempelhof, Nirat Beohar, Chris S. Malaisrie, Patrick M. McCarthy, Charles J. Davidson

January 03, 2012

Presentation TCT 2012

B-Type Natriuretic Peptide Predicts Improvement of Left Ventricular Function and Clinical Outcome After Balloon Aortic Valvuloplasty.

Presenter: Joelle Kefer, Jean-Marie Gapira, Amer Harmouch, Jim Reish, Jean Renkin

January 03, 2012

News Industry News

Two-year study of transcatheter aortic valve replacement demonstrates continued superiority over standard therapy

November 09, 2011

Advertisement

Cerebral Embolization During TAVR Comparable Across Access Routes, Devices

Survey Reflects US Structural Intervention Training in Its ‘Infancy’

Myocardial Injury Common After TAVR

The Role of Balloon Aortic Valvuloplasty in TAVR and as Stand-Alone Therapy

Boston Scientific Announces Positive Data From Lotus™ Transcatheter Aortic Valve Trial

Local Anesthesia Feasible, Safe in Transfemoral TAVR

Loma Vista Medical receives CE mark for its TRUE Dilatation™ Balloon Valvuloplasty Catheter

CMS Agrees to Cover TAVR for FDA-Approved Use

Transseptal Technique, Mitral Balloon Valvuloplasty, and Percutaneous Management of Paravalvular Leaks

PCI with Concomitant Aortic Stenosis May Not Increase Short-term Mortality

Study Focuses on Systemic Inflammation After TAVR

Societies Recommend TAVR Program Requirements

Percutaneous Valve Replacement Stakes Out the Tricuspid

Early Percutaneous Intervention May Help Asymptomatic Mitral Stenosis

Transcatheter aortic valve replacement with a self-expandable bioprosthesis performed without balloon valvuloplasty: comparative results in a consecutive series of patients

The Impact of Commissural Morphology on Clinical Outcome in Patients Undergoing Percutaneous Balloon Mitral Valvuloplasty

Long-term Follow-up of Mitral Valvuloplasty with Single Balloon. Independent Predictors of Survival and Event Free Survival

Balloon Aortic Valvuloplasty as a Bridging Thearpy to Aortic Valve Replacement or Transcatheter Aortic Valve Implantation

B-Type Natriuretic Peptide Predicts Improvement of Left Ventricular Function and Clinical Outcome After Balloon Aortic Valvuloplasty.

Two-year study of transcatheter aortic valve replacement demonstrates continued superiority over standard therapy

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content